Northeastern Section AUA 62nd Annual Meeting • Pittsburgh, PA • September 22-26, 2010.
Subject: Cancer (Care and treatment)
Medical centers
Pub Date: 10/01/2010
Publication: Name: Canadian Urological Association Journal (CUAJ) Publisher: Canadian Urological Association Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2010 Canadian Urological Association ISSN: 1911-6470
Issue: Date: Oct 1, 2010 Source Volume: 4 Source Issue: 5 Suppl 2
Topic: Canadian Subject Form: Medical centres
Product: Product Code: 8000432 Cancer Therapy NAICS Code: 621 Ambulatory Health Care Services
Accession Number: 239214077
Full Text: Thursday, September 23, 2010

7:30 a.m. Opening SessionJoel B. Nelson, Northeastern Section PresidentDatta G. Wagle, American Urological Association President 7:45 - 8:30 a.m. Plenary I: Dermatologic ConditionsJoseph English, University of Pittsburgh Medical Center, Pittsburgh, PA 8:30 - 8:45 a.m. PSA Update:Datta Wagle, Buffalo, NY 8:45 - 9:30 a.m. Plenary II: AUA Practice Guidelines: The Workings and The HighlightsJ. Stuart Wolf, University of Michigan, Ann Arbor, MI 9:30 - 9:45 a.m. Residents DebateTopic: The Management of Upper Tract Urothelial Cancer 9:45 - 10:15 a.m. Break 10:15 - 10:30 a.m. AUA Committee on Male Health UpdateP. Miller Ashman, Rochester, NY 10:30 - 10:50 a.m. Health Policy Update US and Canadian Perspective US Perspective - Ronald KaufmanCanadian Perspective - Darrel Drachenberg 10:50 a.m. - Noon The Section Session: What's New in Female UrologyElise De, University of Pittsburgh Medical Center, Pittsburgh, PAStephen Steele, Queens University, Kingston General Hospital, Kingston, ON, CanadaWendy Leng, University of Pittsburgh Medical Center, Pittsburgh, PASender Herschorn, Sunnybrook Health Sciences Center, Toronto, ON, CanadaModerator: Elise De Noon - 1:30 p.m. Sneak-peek Luncheon in Exhibit Hall 1:30 - 2:30 p.m. Plenary III: Medical Expulsive Therapy for Kidney StonesStephen Nakada, University of Wisconsin School of Medicine and Public Health, Madison, WI 2:30 - 2:45 p.m. Residents DebateTopic: The Management of Kidney Stones in the Morbidly Obese 2:45 - 3:15 p.m. Break in Exhibit Hall 3:15 - 5 p.m. Concurrent Poster Sessions I & II 4 - 5 p.m. Moderated Poster Session I: Basic ScienceModerators: J. Stuart Wolf, JodiMaranchie 4 p.m. P1. Development of a Nanolantern™ Assay for Rapid Detection Of Enterobacter Cloaca.Angelo J. Cambio[sup.1] , Jennifer G. Rothschild [sup.1] , Hsin-P Peng [sup.2] , Robert D. Mayer [sup.1] , Benjamin L. Miller [sup.2].[sup.1]University of Rochester Medical Center, Rochester, NY, USA; [sup.2]University of Rochester, Rochester, NY, USA. 4:03 p.m. P2. WITHDRAWN 4:06 p.m. P3. Nox4 Inhibitor as a Potential Therapeutic Agent for Renal Cell Carcinoma.Li Chen, Guimin Chang, Jodi K. Maranchie. University of Pittsburgh Medical Center, Pittsburgh, PA, USA. 4:09 p.m. P4. A Dual Adenoviral Amplification System Based on PSA-promoter to Increase Sensitivity of Detection of Prostate Cancer Cells in Vivo by Non-invasive Imaging.Frederic Pouliot[sup.1] , Makoto Sato [sup.2] , Lily Wu [sup.2].[sup.1]Laval University, Quebec, QC, Canada; [sup.2]University of California, Los Angeles, Los Angeles, CA, USA. 4:12 p.m. P5. Increased Cancer Cell Proliferation in Prostate Cancer Patients with High Levels of Serum Folate.Jeffrey J. Tomaszewski, Jessica L. Cummings, Anil Parwani, Rajiv Dhir, Joel B. Mason, Joel B. Nelson, Dean J. Bacich, Denise S. O'Keefe.University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 4:15 p.m. P6. Nitric Oxide Signaling Mediates Hypoxic Upregulation of Macrophage Inhibitory Factor in Prostate Cancer.D. Robert Siemens.Queen's University, Kingston, ON, Canada. 4:18 p.m. P7. Reconstruction of a Human Vesical Equivalent Using Adipose-Derived Stem Cells.Alexandre Rousseau, Jonathan Cloutier, Genevieve Bernard, Guillaume Marceau Fortier, Robert Gauvin, Sara Bouhout, Julie Fradette, Stephane Bolduc.LOEX, Centre de recherche FRSQ du CHA universitaire de Quebec, Universite Laval, Quebec, QC, Canada. 4:21 p.m. P8. Stray Electrical Currents in Laparoscopic Instruments Used in DaVinci Robotic Surgery.Carlos E. Mendez Probst[sup.1] , George Vilos [sup.1] , Paul Borg [sup.2] , David Galloway [sup.2] , Stephen E. Pautler [sup.1].[sup.1]Schulich School of Medicine and Dentistry, The University of Western Ontario, London, ON, Canada; [sup.2]St Joseph's Health Care London, London, ON, Canada. 4:24 p.m. P9. Vitamin D3 Therapy Increases Cryoablation Efficacy: A Novel Strategy for the Treatment of Prostate Cancer.John M. Baust, PhD[sup.1] , Daniel Klossner, Anthony Robilotto [sup.1] , Robert Van Buskirk [sup.1] , Andrew Gage [sup.1] , Vladimir Mouraviev[sup.3], Thomas Polascik[sup.3], John G. Baust [sup.2].[sup.1]CPSI Biotech, Owego, NY, USA; [sup.2]Binghamton University, Binghamton, NY, USA; [sup.3]Duke University Medical Center, Durham, NC, USA. 4:27 p.m. P10. Rapid Induction of Apoptosis at Ultra Low Temperatures Enhances the Efficacy of Prostate Cancer Cryoablation.Anthony Robilotto, John M. Baust [sup.1] , Robert VanBuskirk [sup.1] , Andrew Gage [sup.1] , John G. Baust [sup.2].[sup.1]CPSI Biotech, Owego, NY, USA; [sup.2]Binghamton University, Binghamton, NY, USA. 4:30 p.m. P11. The VHL Tumor Suppressor Promotes Renal Cancer Cell Apoptosis by Inhibiting Casein Kinase 2 Activity and Impairing NF- B Signaling.Guan Wu, Xiangrong He, Edward M. Messing.University of Rochester, Rochester, NY, USA. 4:33 p.m. P12. The Effect of Dietary Folate on Prostate Carcinogenesis in an in Vivo Model of Tumorigenesis.Jeffrey J. Tomaszewski, Jessica L. Cummings, Anil Parwani, Dean J. Bacich, Denise S. O'Keefe.University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 4:36 p.m. P13. Nox4 is Required for Nuclear Translocation of HIF-2 in Renal Cancer Cells.Guimin Chang, PhD, Li Chen, PhD, Jodi K. MaranchieUniversity of Pittsburgh Medical Center, Pittsburgh, PA, USA. 4:39 p.m. P14. Temporal RF-Ultrasound Augmentation Of Prostate (TRAP): Enhancing Prostate CancerDetection Utilizing Temporal Ultrasound Radio Frequency Signals.D. Robert Siemens, Purang Abolmaesumi, Parvin Mousavi, Mehdi Moradi, Eric Sauerbrei, Sandy Boag.Queen's University, Kingston, ON, Canada. 4:42 p.m. P15. Urinary MicroRNA as an Accurate Urinary Diagnostic Marker for Urothelial Cancer.D. Robert Siemens, Jaime Snowden, Jason Izard, Sandy Boag, Harriet Feilotter.Queen's University, Kingston, ON, Canada. 4:45 p.m. P16. Development of a Realtime Intraoperative Electrical Impedance Tomography Sensor for Cavernous Nerve Mapping for Radical Prostatectomy.Henry H. Tran, University of British Columbia, New Westminster, BC, Canada. 4:48 p.m. P17. Mapping the Cytokine Profile of Interstitial Cystitis in Human Bladder and Urine Specimens: A Pilot Study.Anthony T. Corcoran[sup.1] , Vikas Tyagi [sup.1] , Masa Kita [sup.1] , Pradeep Tyagi [sup.2] , Wendy W. Leng [sup.1] , Naoki Yoshimura [sup.1].[sup.1]University of Pittsburgh Medical Center, Pittsburgh, PA, USA; [sup.2]William Beaumont Hospital, Royal Oak, MI, USA. 4:51 p.m. P18. Targeted Modulation of Integrin Expression Increases Freeze Sensitivity of Androgen-Insensitive Prostate Cancer.John M. Baust[sup.1] , Daniel Klossner [sup.2] , Robert VanBuskirk [sup.1] , Andrew Gage [sup.1] , Vladimir Mouraviev [sup.3] , Thomas Polascik [sup.3] , John G. Baust[sup.4] .[sup.1]CPSI Biotech, Owego, NY, USA; [sup.2]Binghamton University, Binghamton, NY, USA; [sup.3]Duke University Medical Center, Durham, NC, USA; [sup.4]Binghamton University, Binghamton, NY, USA. 4:54 p.m. Discussion 5 p.m. Adjourn 4 - 5 p.m. Moderated Poster Session II: Kidney CancerModerators: Stephen Nakada, Neil Fleshner 4 p.m. P19. Synchronous Presence of Renal Pelvic And Ureteral Tumors Is Independently Prognostic of Survival Following Radical Nephrectomy.Faysal A. Yafi[sup.1] , Shahrokh Shariat [sup.2] , Giacomo Novara [sup.3] , Amit Gupta [sup.2] , Kazumasa Matsumoto4, Thomas J. Walton [sup.5] , Hans-Martin Fritsche [sup.6] , Patrick J. Bastian [sup.7] , Juan I. Martínez-Salamanca [sup.8] , Christian Seitz [sup.9] , Vincenzo Ficarra [sup.3] , Pierre I. Karakiewicz [sup.1] [sup.0], Wassim Kassouf [sup.1].[sup.1]McGill University, Montreal, QC, Canada; [sup.2]University of Texas Southwestern Medical Center, Dallas, TX, USA; [sup.3]University of Padua, Padua, Italy; [sup.4]Kitasato University School of Medicine, Sagamihara, Japan; [sup.5]Derby City General Hospital, Derby, United Kingdom; [sup.6]Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; [sup.7]Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany; [sup.8]Hospital Universitario Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid, Madrid, Spain; [sup.9]General Hospital Bolzano, Bolzano, Italy; [sup.10]University of Montreal, Montreal, QC, Canada. 4:03 p.m. P20. Renal Cell Carcinoma in the Elderly: Is Partial Nephrectomy the Right Surgical Option?Matthew H. Hayn [sup.1] , Nicholas J. Hellenthal [sup.1] , Rebecca O'Malley[sup.1] , Hyung Kim [sup.2] , Willie Underwood [sup.1] ,Thomas Schwaab [sup.1].[sup.1]Roswell Park Cancer Institute, Buffalo, NY, USA; [sup.2]Cedars-Sinai Medical Center, Los Angeles, CA, USA. 4:06 p.m. P21. Laparoscopic Partial Nephrectomy Guided by Near Infrared Fluorescence (NIRF) of Intravenous Indocyanine Green (ICG).Joy K. Knopf, Scott Tobis, Guan Wu, Hani Rashid, Christopher R. Silvers, Jonah Marshall, Jorge Yao, Edward M. Messing, Dragan J. Golijanin.University of Rochester, Rochester, NY, USA. 4:09 p.m. P22. Small Renal Mass Needle Biopsy: Outcomes of Non-Diagnostic Percutaneous Biopsy and Rate of Repeat Biopsy.Michael Jewett [sup.1] , Michael Leveridge [sup.2] , John R. Kachura[sup.2], Andrew J. Evans[sup.2], Antonio Finelli[sup.2] .[sup.1]University of Toronto, Toronto, ON, Canada, [sup.2]Princess Margaret Hospital, Toronto, ON, Canada. 4:12 p.m. P23. Patterns of Non-surgical Management of Small Renal Masses: A Population-based Analysis.Rupinder Johal[sup.1] , Firas Abdollah [sup.1] , Lars Budaus [sup.2] , Rodolphe Thuret[sup.3], Maxine Sun [sup.1] , Monica Morgan [sup.1] , Daniel Liberman [sup.1] , Giovanni Lughezzani[sup.4], Claudio Jeldres [sup.1] , Al'a Abdo [sup.1] , Salima Ismail [sup.1] , Shahrokh F. Shariat [sup.1] , Paul Perrotte [sup.5] , Francesco Montorsi[sup.4], Markus Graefen [sup.6] , Pierre I. Karakiewicz [sup.1].[sup.1]Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC, Canada; [sup.2]Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; [sup.3]Urology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France; [sup.4]Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; [sup.5]Department of Urology, University of Montreal Health Center, Montreal, QC, Canada; [sup.6]Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 4:15 p.m. P24. A Population-based Analysis of Perioperative Complications and Mortality Associated with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.Rupinder Johal[sup.1] , Giovanni Lughezzani [sup.2] , Lars Budaus[sup.3], Rodolphe Thuret[sup.4], Firas Abdollah [sup.1] , Maxine Sun [sup.1] , Monica Morgan [sup.1] , Daniel Liberman [sup.1] , Salima Ismail [sup.1] , Al'a Abdo [sup.1] , Markus Graefen [sup.5] , Paul Perrotte [sup.6] , Shahrokh F. Shariat [sup.1] , Francesco Montorsi [sup.2] , Pierre I. Karakiewicz [sup.1].[sup.1]Cancer Prognosis and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada; [sup.2]Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; [sup.3]Department of Urology, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; [sup.4]Department of Urology, Montpellier University Hospital, Montpellier, France; [sup.5]Department of Urology, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; [sup.6]Department of Urology, University of Montreal, Montreal, QC, Canada. 4:18 p.m. P25. Percutaneous Radiofrequency Ablation of Small Renal Tumors: McGill University Initial Experience.Nader Fahmy, Tatiana Cabrera, David Valenti, Maurice Anidjar.McGill University, Montreal, QC, Canada. 4:21 p.m. P26. Renal Cell Carcinoma in Octogenarians: Comprehensive Analysis Using the Seer Database.Matthew Hayn, Nicholas J. Hellenthal, Willie Underwood, Thomas Schwaab.Roswell Park Cancer Institute, Buffalo, NY, USA. 4:24 p.m. P27. Utilization Rates of Open Partial Nephrectomy and Laparoscopic Radical Nephrectomy in Patients with Nonmetastatic Renal Cell Carcinoma.Monica Morgan[sup.1] , Daniel Liberman [sup.1] , Rupinder Johal [sup.1] , Maxine Sun [sup.2] , Salima Ismail [sup.1] , Lars Budaus [sup.1] , Giovanni Lughezzani[sup.3], Firas Abdollah [sup.2] , Shahrokh F. Shariat [sup.2] , Markus Graefen [sup.4] , Paul Perrotte [sup.2] , Pierre I. Karakiewicz [sup.2].[sup.1]University of Montreal Health Centre, Montreal, QC, Canada; [sup.2]Cancer Prognostics and Health Outcomes Unit, Montreal, QC, Canada; [sup.3]Vita-Salute University San Raffaele, Milan, Italy; [sup.4]Martiniclinic, University Hospital Hamburg-Eppendorf, Hamburg, Germany. 4:27 p.m. P28. A Population-based Analysis of the Perioperative Outcomes of Open Partial Versus Open Radical Nephrectomy.Rupinder Johal[sup.1] , Claudio Jeldres [sup.1] , Giovanni Lughezzani [sup.2] , Rodolphe Thuret [sup.3] , Lars Budaus [sup.4] , Maxine Sun [sup.1] , Firas Abdollah [sup.1] , Monica Morgan [sup.1] , Daniel Liberman [sup.1] , Salima Ismail [sup.1] , Al'a Abdo [sup.1] , Shahrokh F. Shariat [sup.1] , Markus Graefen [sup.4] , Paul Perrotte [sup.1] , Pierre I. Karakiewicz [sup.1].[sup.1]Department of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada; [sup.2]Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; [sup.3]Urology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France; [sup.4]Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 4:30 p.m. P29. The Rates of Metastatic Renal Cell Carcinoma are Decreasing Over Time: A Population-based Analysis.Monica Morgan[sup.1] , Rupinder Johal, [sup.1] , Maxine Sun, BSc [sup.2] , Daniel Liberman [sup.1] , Ala Abdo [sup.1] , Lars Budaus [sup.3] , Rodolphe Thuret [sup.2] , Salima Ismail [sup.1] , Paul Perrotte [sup.2] , Pierre I. Karakiewicz [sup.2].[sup.1]University of Montreal Health Centre, Montreal, QC, Canada; [sup.2]Cancer Prognostics and Health Outcomes Unit, Montreal, QC, Canada; [sup.3]Martiniclinic, University Hospital Hamburg-Eppendorf, Hamburg, Germany. 4:33 p.m. P30. Percutaneous Ablation of Renal Masses: The Albany Medical Center Experience.Michael A. Feuerstein, Badar M. Mian, Hugh Fisher, Ronald Kaufman Jr.Albany Medical College, Albany, NY, USA. 4:36 p.m. P31. Advanced Techniques in Renal Radiofrequency Ablation.Scott Tobis, Devang Butani, Wael Saad, Nikhil Patel, Erdal Erturk.University of Rochester Medical Center, Rochester, NY, USA. 4:39 p.m. P32. Selective Arterial Embolizations (SAE) of Renal Angiomyolipomas (AML): A Single Institution Experience.Scott Tobis, Joy Knopf, David Waldman, Edward Messing, Erdal Erturk, Dragan Golijanin.University of Rochester Medical Center, Rochester, NY, USA. 4:42 p.m. P33. Predictors of Health-Related Quality of Life Recovery Following Laparoscopic Simple, Radical and Donor Nephrectomy.Joshua D. Wiesenthal, Trevor Schuler, R. John D'A. Honey, Kenneth T. Pace.University of Toronto, Toronto, ON, Canada. 4:45 p.m. P34. Transumbilical Laparoendoscopic Single-Site (U-LESS) Nephrectomy: Initial Experience of 16 Cases.Guan Wu, Jonah Marshall, Scott Tobis, Dragan J. Golijanin, Hani Rashid.University of Rochester, Rochester, NY, USA. 4:48 p.m. Discussion 5 p.m. Adjourn 5 - 6 p.m. Industry-sponsored Symposium 6 - 7 p.m. Exhibit Hall Grand Opening/Welcome Reception

Friday, September 24, 2010

7 - 8 a.m. 5K Run/Walk 7:30 - 7:45 a.m. Best-of-Poster SessionsPresented by moderators of previous day's poster sessions 7:45 - 8:45 a.m. Plenary IV: Section Stars (Prize-Winning Essays & Past NS Scholars) 8:45 - 9:30 a.m. Plenary VUrology Education and SimulationElspeth McDougall, UCI Medical Center, Orange, CA 9:30 - 9:45 a.m. Residents DebateTopic: The Management of a Large Kidney Stone 9:45 - 10:15 a.m. Break in Exhibit Hall 10:15 - Noon Concurrent Poster Sessions III & IV 11 a.m. - Noon Moderated Poster Session III: Assorted Urology TopicsModerators: Elspeth McDougall, Kenneth Pace 11 a.m. P35. Percutaneous Nephrolithotomy in the Prone-Flexed Position: Is There an Optimal Access?R. John D'A. Honey, Joshua D. Wiesenthal, Daniela Ghiculete, Steven Pace, Kenneth T. Pace.University of Toronto, Toronto, ON, Canada. 11:03 a.m. P36. Effective Radiation Exposure in Follow up of Patientswith Nephrolithiasis.Nader Fahmy, Sero Andonian.McGill University, Montreal, QC, Canada. 11:06 a.m. P37. Predictors of Outcome of Percutaneous Nephrolithotomy.Khaled Shahrour, Jeffrey Tomaszewski, Tara Ortiz, Kevan Sternberg, Li Wang, Marc Smaldone, Stephen Jackman, Timothy Averch.University of Pittsburgh, Pittsburgh, PA, USA. 11:09 a.m. P38. Single Institution Review of the Incidence of Perinephric Hematoma after Shock Wave Lithotripsy.Rasmus Leistner, Carlos E. Mendez-Probst, Linda Nott, RN, Petar Erdeljan, Sumit Dave, Hassan Razvi.Schulich School of Medicine and Dentistry, The University of Western Ontario, London, ON, Canada. 11:12 a.m. P39. Intermediate-sized Urolithiasis: The Equivalency of Treatment Modalities.Joshua D. Wiesenthal, Daniela Ghiculet, R. John D'A Honey, Kenneth T. Pace.University of Toronto, Toronto, ON, Canada. 11:15 a.m. P40. Ambulatory Percutaneous Nephrolithotomy: Initial Series.Walid Shahrour, Sero Andonian.McGill University, Montreal, QC, Canada. 11:18 a.m. P41. Radiation Exposure during Percutaneous Nephrolithotomy in a Contemporary Series.Walid Shahrour, Sero Andonian, Konrad Szymanski.McGill University, Montreal, QC, Canada. 11:21 a.m. P42. Tibial Nerve Neuromodulation of Bladder Activity in Cats.Mang L. Chen[sup.1] , Bing Shen [sup.2] , Jicheng Wang [sup.1] , Hailong Liu [sup.1] , James Roppolo [sup.2] , William de Groat [sup.2] , Changfeng Tai [sup.1].[sup.1]University of Pittsburgh Medical Center, Pittsburgh, PA, USA; [sup.2]University of Pittsburgh Dept of Pharmacology, Pittsburgh, PA, USA. 11:24 a.m. P43. WITHDRAWN 11:27 a.m. P44. Standard of Care Outcomes Using Mesh Products ("Perigee" and "Apogee") for Treating Female Pelvic Prolapse in 170 Patients -- Single Surgeon Experience.Erin Bowser, DO [sup.1] , Ratna Ganabathi [sup.2] , Kumaresan Ganabathi[sup.1].[sup.1]Clarion Hospital, Clarion, PA, USA, [sup.2]Lake Erie Osteopathic College of Medicine, Erie, PA, USA. 11:30 a.m. P45. Pelvic Floor Reconstruction with Customized Mesh.Kenneth K. Hu, Julian Tolentino, Marydonna Ravasio, John Glaser, Aaron Schlott.Butler Memorial Hospital, Butler, PA, USA. 11:33 a.m. P46. A Trial of Bilateral Percutaneous Nephrostomy Tube Placement in Refractory Non-ulcerative Interstitial Cystitis Patients Prior to Simple Urinary Diversion.Mini Varghese, Robert D. Mayer.University of Rochester, Rochester, NY, USA. 11:36 a.m. P47. Modified Scrotal (Bianchi) Mid-raphe Single-Incision Orchidopexy for Palpable Undescended Testis.Jonathan Cloutier, Katherine Moore, Vincent Fradet, Stephane Bolduc.Laval University, Quebec, QC, Canada. 11:39 a.m. P48. Renal Perfusion Pump vs. Cold Storage for Donation after Cardiac Death Kidneys: A Systematic Review.Thomas B. McGregor, Varunkumar Bathini, Vivian McAlister, Patrick Luke, Alp Sener.University of Western Ontario, London, ON, Canada. 11:42 a.m. Discussion Noon Adjourn 11 a.m. - Noon Moderated Poster Session IV: Prostate and Testes CancerModerators: Dragan Goliganin, Gabriel Haas 11 a.m. P49. Aggressive Urologic Malignancy in Heart Transplant Recipients.Abhijith D. Mally, Bruce L. Jacobs, Jeffrey Tomaszewski, Jeffrey Teuteberg, Yoshiya Toyoda, Diana Zaldonis, Stephen V. Jackman.University of Pittsburgh, Pittsburgh, PA, USA. 11:03 a.m. P50. Risk of Secondary Malignancy in Patients with Testicular Cancer is Increased with Radiotherapy.Dan Lewinshtein, Christopher PorterVirginia Mason Medical Center, Seattle, WA, USA. 11:06 a.m. P51. Stage-Specific Population-based Trends of RPLND Use.Daniel Liberman [sup.1] , Lars Badaus [sup.2] , Giovanni Lughezzani [sup.3] , Ala Abdo [sup.1] , Maxine Sun [sup.1] , Monica Morgan [sup.1] , Rodolphe Thuret [sup.4] , Salima Ismail [sup.1] , Wassim Kassouf [sup.5] , Hugues Widmer [sup.1] , Francesco Montorsi [sup.3] , Paul Perrotte [sup.1] , Shahrokh F. Shariat [sup.1] , Pierre I. Karakiewicz [sup.1].[sup.1]University of Montreal Health Center, Montreal, QC, Canada; [sup.2]Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany; [sup.3]Vita-Salute San Raffaele, Milan, Italy; [sup.4]Centre Hospitalier Universitaire de Montpellier, Montpellier, France, [sup.5]McGill University, Montreal, QC, Canada. 11:09 a.m. P52. Decreased Survival of Black Americans with Testicular Cancer: A Contemporary Population-based Analysis.Daniel Liberman, [sup.1] Lars Badaus [sup.2] , Monica Morgan [sup.1] , Rupinder Johal [sup.1] , Maxine Sun [sup.1] , Ala Abdo [sup.1] , Giovanni Lughezzani [sup.3] , Rodolphe Thuret [sup.4] , Wassim Kassouf [sup.5] , Hugues Widmer [sup.1] , Francesco Montorsi [sup.3] , Shahrokh F. Shariat [sup.1] , Paul Perrotte [sup.1] , Pierre I. Karakiewicz [sup.1].[sup.1]University of Montreal Health Center, Montreal, QC, Canada; [sup.2]Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany; [sup.3]Vita-Salute San Raffaele, Milan, Italy; [sup.4]Centre Hospitalier Universitaire de Montpellier, Montpellier, France; [sup.5]McGill University, Montreal, QC, Canada. 11:12 a.m. P53. Toremifene 80 mg Demonstrates Reduction in Fracture Risk in Men Who are Less than 80 Years of Age on Androgen Deprivation Therapy.Philip J. Aliotta[sup.1] , Ronald Kaufman [sup.2] , Michael Brawer [sup.3] , Ronald A. Morton [sup.4] , Mark D. Chazen [sup.1] , John V. Pinski [sup.1].[sup.1]Main Urology Associates P.C., Buffalo, NY, USA; [sup.2]Community Care, Alband, NY, USA; [sup.3]GTx, Inc., Memphis, TN, USA; [sup.4]GTx, Inc, Memphis, TN, USA. 11:15 a.m. P54. Effect of Posterior Reconstruction of the Rhabdosphincter on Early PostoperativeContinence Following Robotic-assisted Radical Prostatectomy: A Comparison of Two Matched Groups.Ahmed Ghazi, Granville Lloyd, Mathew Lux, Hitendra Patel, Jean Joseph.University of Rochester, Rochester, NY, USA. 11:18 a.m. P55. Integrated Safety Results from 4 Randomized, Double-blind, Placebocontrolled Studies of Sipuleucel-T.Neal D. Shore[sup.1] , Simon J. Hall [sup.2] , Paul F. Schellhammer [sup.3] , Celestia S. Higano [sup.4] , John M. Corman [sup.5] , Tomasz M. Beer [sup.6] , Eric J. Small [sup.7] , Allan J. Pantuck [sup.8] , Vahan S. Kassabian [sup.9] , Frances P. Stewart [sup.10] , Robert B. Sims [sup.10].[sup.1]Grand Strand Urology, Myrtle Beach, SC, USA; [sup.2]Mount Sinai School of Medicine, New York, NY, USA; [sup.3]Eastern Virginia Medical School, Norfolk, VA, USA; [sup.4]University of Washington, Seattle, WA, USA; [sup.5]Virginia Mason Medical Center, Seattle, WA, USA, [sup.6]Oregon Health and Sciences University, Portland, OR, USA; [sup.7]University of California, San Francisco, San Francisco, CA, USA; [sup.8]University of California, Los Angeles, Los Angeles, CA, USA; [sup.9]Georgia Urology, Marietta, GA, USA; [sup.10]Dendreon Corporation, Seattle, WA, USA. 11:21 a.m. P56. Therapeutic Value of Lymph Node Dissection at Radical Prostatectomy: A Population-based Retrospective Study.D. Robert Siemens, Diana Withrow, Julie De Groot, Patti Groome.Queen's University, Kingston, ON, Canada. 11:24 a.m. P57. Trans-rectal Ultrasound Volume Estimation: How Much it Can Be Trusted when Choosing the Best Treatment for Localized Prostate Cancer?Murilo Luz, Simone Chevalier, Armen Aprikian, Alan Dal Pra, Eleonora Scarlata, Lucie Hamel, Fabio Cury.McGill University, Montreal, QC, Canada. 11:27 a.m. P58. The Natural History and Cause of Death of Men in whom Metastatic Prostate Cancer Developed Following Radical Prostatectomy.Dan Lewinshtein, Christopher Porter.Virginia Mason Medical Center, Seattle, WA, USA. 11:30 a.m. P59. Is Post chemotherapy Retroperitoneal Lymphadenectomy Necessary after Complete Response.Michael Jewett, Jeremy Sturgeon, Lynn Anson-Cartwright, Padraig R. Warde, Mary Gospodarowicz, Malcolm J. Moore.Princess Margaret Hospital, Toronto, ON, Canada. 11:33 a.m. P60. Outcomes of Patients with Localized Prostate Cancer Treated with Radical Prostatectomy: The Experience of a Single Canadian Institution.Yasser A. Jamalalail. University of Ottawa, Ottawa, ON, Canada. 11:36 a.m. P61. Comparative Cost-analysis of Roboticassisted Laparoscopic Prostatectomy and Open Prostatectomy.Jeffrey J. Tomaszewski, Benjamin Davies, Stephen V. Jackman, Ronald L. Hrebinko, Joel B. Nelson.University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 11:39 a.m. Discussion Noon Adjourn Noon - 1:30 p.m. Lunch in Exhibit Hall 1:30 - 2:15 p.m. Slotkin LectureIrreparable Vesicovaginal Fistulas from Birth Trauma or Sexual Violence in Africa: Difficult Solutions for Desperate Circumstances.Joseph A. Smith, Vanderbilt University Medical Center, Nashville, TN 2:15 - 2:30 p.m. Residents DebateTopic: The Management of Localized Prostate Cancer 2:30 - 3 p.m. Break 3- 4:30 p.m. Concurrent Poster Sessions V & VI 3:35 - 4:30 p.m. Moderated Poster Session V: General Urology and InfertilityModerators: Julie Franc-Guimond, Ron Benoit 3:35 p.m. P62. Androgen Inducible Genes in Human Prostate Stromal Cells.Charles Welliver[sup.1] , Matthew Tanner [sup.2] , Mengqian Chen [sup.2] , Michael Shtutman [sup.2] , Badar Mian [sup.1] , Ralph Buttyan [sup.2].[sup.1]Albany Medical Center, Albany, NY, USA; [sup.2]Ordway Research Institute, Albany, NY, USA. 3:38 p.m. P63. Role of Pelvic Floor Release (Osteopathic Technique) in the Management of Symptoms Associated with Chronic Non-bacterial Prostatitis (Type III) - A Pilot Study.Erin Bowser, Kumaresan Ganabathi.Clarion Hospital, Clarion, PA, USA. 3:41 p.m. P64. Clavien Classification of Surgical Complications Applied to Urological Procedures and Evaluated According to Training Level.Murilo Luz, Saad Aldousari, Armen Aprikian.McGill University, Montreal, QC, Canada. 3:44 p.m. P65. Photoselective Vaporization of The Prostate: Technical and Clinical Differences between Potassium Titanyl Phosphate and Lithium Triborate Lasers in Prostates <80 Gm.Hazem M. Elmansy, Mostafa M. Elhilali.McGill University, Montreal, QC, Canada. 3:47 p.m. P66. New Sonographically Detected Voiding Urethral Regurgitation may be Initiating Factor in LUTS/CPPS.Roger E. Vega.UPMC St. Margaret, Kittanning, PA, USA. 3:50 p.m. P67. Combined Anticholinergic Therapy with Long Term Follow-up in Refractory Overactive Bladder.Susan J. Marshall, Kevin Pranikoff.Department of Urology, State University of New York at Buffalo, Erie County Medical Center, Buffalo, NY, USA. 3:53 p.m. P68. Relationship between Prostate Volume and Silodosin-Mediated Improvement of Symptoms Associated with Benign Prostatic Hyperplasia.Steven A. Kaplan [sup.1] , Claus Roehrborn [sup.2] , Lawrence A. Hill[sup.3] , Weining Volinn [sup.3] , Gary Hoel [sup.3].[sup.1]Weill Cornell Medical College, New York, NY, USA; [sup.2]UT Southwestern Medical Center, Dallas, TX, USA; [sup.3]Watson Laboratories, Salt Lake City, UT, USA. 3:56 p.m. P69. Detection of Vitamin D Deficiency in a General Urology Practice.Frank J. Costa. Urology Institute of Pittsburgh, Pittsburgh, PA, USA. 3:59 p.m. P70. WITHDRAWN 4:02 p.m. P71. WITHDRAWN 4:05 p.m. P72. Do Urologic Procedures such as Prostate Needle Biopsy and Vasectomy Cause Erectile Dysfunction?Dan Lewinshtein, Christopher Porter.Virginia Mason Medical Center, Seattle, WA, USA. 4:08 p.m. P73. WITHDRAWN 4:11 p.m. P74. WITHDRAWN 4:14 p.m. P75. Penile Injury is Apparently not the Underlying Etiology for Peyronie's Disease in 450 Consecutive Canadian Men: A Single Center Results.Rany Shamloul, Anthony J. Bella.University of Ottawa, Ottawa, ON, Canada. 4:17 p.m. P76. Sex, Sexuality and Procreation in Complex Urogenital Anomalies.Emmanuel O. Abara.York Central Hospital, Richmond Hill, ON, Canada. 4:20 p.m. Discussion 4:30 p.m. Adjourn 3:35 - 4:30 p.m. Moderated Poster Session VI: Bladder and Penile CancerModerators: Joseph A. Smith, Benjamin Davies 3:35 p.m. P77. Single or Multiple Positive Nodes at Lymphadenectomy Have Similar Cancerspecific Survival in Patients Treated for Penile Squamous Cell Carcinoma.Rupinder Johal[sup.1] , Claudio Jeldres [sup.1] , Giovanni Lughezzani [sup.2] , Lars Budaus [sup.3] , Rodolphe Thuret [sup.4] , Firas Abdollah [sup.5] , Maxine Sun [sup.1] , Monica Morgan [sup.5] , Daniel Liberman [sup.5] , Salima Ismail [sup.5] , Al'a Abdo [sup.5] , Paul Perrotte [sup.5] , Shahrokh F. Shariat [sup.5] , Francesco Montorsi [sup.6] , Pierre I. Karakiewicz [sup.1].[sup.1]Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada; [sup.2]Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; [sup.3]Department of Urology, Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamberg, Germany; [sup.4]Department of Urology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France; [sup.5]Department of Urology, Cancer Prognostics and Health Outcomes Unit, University of M, Montreal, QC, Canada; [sup.6]Department of Urology, Vita-Salute San Raffaele University, Milan, Italy. 3:38 p.m. P78. WITHDRAWN 3:41 p.m. P79. Radical Cystectomy for Clinically Muscle Invasive Bladder Cancer: Does Prior Superficial Disease Affect Clinical Outcomes?Ahmed F. Kotb[sup.1] , Wassim Kassouf [sup.1] , Joe Chin [sup.2] , Yves Fradet [sup.3] , Jonathan Izawa [sup.2] , Eric Estey [sup.4] , Adrian Fairey [sup.4] , Ricardo Rendon [sup.5] , Ilias Cagiannos [sup.6] , Louis Lacombe [sup.3] , Jean-Baptiste Lattouf [sup.7] , David Bell [sup.5] , Darrel Drachenberg [sup.8] , Armen G. Aprikian [sup.1].[sup.1]McGill University Health Center, Montreal, QC, Canada; [sup.2]University of Western Ontario, London, ON, Canada; [sup.3]Laval University, Quebec, QC, Canada; [sup.4]University of Alberta, Edmonton, AB, Canada; [sup.5]Dalhousie University, Halifax, NS, Canada; [sup.6]University of Ottawa, Ottawa, ON, Canada; [sup.7]University of Montreal, Montreal, QC, Canada; [sup.8]University of Manitoba, Winnipeg, MB, Canada. 3:44 p.m. P80. Survival after Radical Cystectomy of Non-bilharzial Squamous Cell Carcinoma vs. Urothelial Carcinoma: A North American Population-based Study.Daniel Liberman[sup.1] , Claudio Jeldres [sup.1] , Giovanni Lughezzani [sup.2] , Lars Badaus [sup.3] , Monica Morgan [sup.1] , Ala Abdo [sup.1] , Rupinder Johal [sup.1] , Maxine Sun [sup.1] , Shahrokh F. Shariat [sup.1] , Hugues Widmer [sup.1] , Paul Perrotte [sup.1] , Francesco Montorsi [sup.2] , Markus Graefen [sup.3] , Pierre I. Karakiewicz [sup.1].[sup.1]University of Montreal Health Center, Montreal, QC, Canada; [sup.2]Vita-Salute San Raffaele, Milan, Italy; [sup.3]Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany. 3:47 p.m. P81. Induction of CTL-attracting Chemokines and Local Suppression of Treg-attracting Chemokines in Recurrent Bladder Cancer Requires the Combination of BCG with Interferon-a and Toll-like Receptor Ligands.Jeffrey Larson, Jeffrey Gingrich, Ravikumar Mathuswamy, Pawel Kalinski.University of Pittsburgh, Pittsburgh, PA, USA. 3:50 p.m. P82. Defining Morbidity of Robot-assisted Radical Cystectomy Using a Standardized Reporting Methodology.Matthew H. Hayn, Nicholas J. Hellenthal, Abid Hussain, Andrew Steggman, Khurshid A. Guru.Roswell Park Cancer Institute, Buffalo, NY, USA. 3:53 p.m. P83. Personalized Management Of Upper Urinary Tract Urothelial Carcinoma: The Effect of Age on Cancer-specific Mortality.Daniel Liberman[sup.1] , Monica Morgan [sup.1] , Rupinder Johal [sup.1] , Ala Abdo [sup.1] , Hendrik Isbarn [sup.2] , Lars Badaus [sup.2] , Claudio Jeldres [sup.1] , Giovanni Lughezzani [sup.3] , Maxine Sun [sup.1] , Shahrokh F. Shariat [sup.1] , Paul Perrotte [sup.1] , Francesco Montorsi3, Markus Graefen [sup.2] , Pierre I. Karakiewicz [sup.1].[sup.1]University of Montreal Health Center, Montreal, QC, Canada; [sup.2]Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany; [sup.3]Vita-Salute San Raffaele, Milan, Italy. 3:56 p.m. P84. The Perioperative Mortality is Significantly Higher in Septuagenarian and Octogenarian Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder.Daniel Liberman[sup.1] , Ala Abdo [sup.1] , Monica Morgan [sup.1] , Salima Ismail [sup.1] , Rupinder Johal [sup.1] , Giovanni Lughezzani [sup.1] , Lars Badaus [sup.2] , Hugues Widmer [sup.1] , Markus Graefen [sup.2] , Francesco Montorsi [sup.3] , Shahrokh F. Shariat [sup.1] , Paul Perrotte [sup.1] , Pierre I. Karakiewicz [sup.1].[sup.1]University of Montreal, Montreal, QC, Canada; [sup.2]Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany; [sup.3]Vita-Salute San Raffaele, Milan, Italy. 3:59 p.m. P85. Factors Affecting Wait Times for TransurethralBladder Cancer Surgery.Greg Gin, Adam Walker, Barry Kogan.Albany Medical Center, Albany, NY, USA. 4:02 p.m. P86. Neoadjuvant Chemotherapy as a Predictor of Cost, Readmission and Length of Stay in Radical Cystectomy Patients.Deep B. Trivedi, Jennifer B. Gordetsky, Guan Wu, Changyong Feng, Susan Messing, Nathaniel Robbins, Thomas Pashalides, Ingrid Mikk, Hani Rashid, Dragan Golijanin, Katia Noyes, Edward Messing.University of Rochester, Rochester, NY, USA. 4:05 p.m. P87. Continent vs. Incontinent Urinary Diversion after Radical Cystectomy for Urothelial Carcinoma of the Bladder: Comparison of Utilization and Complication Rates.Monica Morgan[sup.1] , Rupinder Johal [sup.1] , Daniel Liberman [sup.1] , Salima Ismail [sup.1] , Ala Abdo [sup.1] , Maxine Sun [sup.1] , Firas Abdollah [sup.2] , Giovanni Lughezzani [sup.3] , Shahrokh F. Shariat [sup.2] , Paul Perrotte [sup.1] , Pierre I. Karakiewicz [sup.1].[sup.1]University of Montreal Health Centre, Montreal, QC, Canada; [sup.2]Cancer Prognostics and Health Outcomes Unit, Montreal, QC, Canada; [sup.3]Vita-Salute University San Raffaele, Milan, Italy. 4:08 p.m. P88. The Rates of Metastatic Bladder Cancer are Increasing Over Time: A Population-based Analysis.Monica Morgan[sup.1] , Rupinder Johal [sup.1] , Daniel Liberman [sup.1] , Ala Abdo [sup.1] , Salima Ismail [sup.1] , Maxine Sun [sup.2] , Claudio Jeldres [sup.1] , Rodolphe Thuret [sup.2] , Shahrokh F. Shariat [sup.2] , Lars Budaus [sup.2] , Markus Graefen [sup.3] , Paul Perrotte [sup.2] , Pierre I. Karakiewicz [sup.2].[sup.1]University of Montreal Health Centre, Montreal, QC, Canada; [sup.2]Cancer Prognostics and Health Outcomes Unit, Montreal, QC, Canada; [sup.3]Martiniclinic, Prostate Cancer Center University Hospital Hamburg-Eppendorf, Hamburg, Germany. 4:11 p.m. P89. Specificity of Urinary Cytology in the Detection and Surveillance of Bladder Cancer: A Contemporary Analysis and Comparison with Other Urine Markers.Faysal A. Yafi, Fadi Brimo, Armen G. Aprikian, Simon Tanguay, Manon Auger, Wassim Kassouf.McGill University, Montreal, QC, Canada. 4:14 p.m. P90. Prostatic Stromal Invasion: A Unique Entity in Patients Treated with Radical Cystectomy for Transitional Cell Carcinoma of the Bladder.Rupinder Johal[sup.1] , Daniel Liberman [sup.1] , Rodolphe Thuret [sup.2] , Lars Budaus [sup.3] , Maxine Sun [sup.4] , Firas Abdollah [sup.5] , Monica Morgan [sup.1] , Salima Ismail [sup.1] , Al'a Abdo [sup.1] , Claudio Jeldres [sup.1] , Paul Perrotte [sup.1] , Shahrokh F. Shariat [sup.5] , Francesco Montorsi [sup.6] , Markus Graefen [sup.7] , Pierre Karakiewicz [sup.5].[sup.1]University of Montreal Health Center, Dept. of Urology, Montreal, Canada, Montreal, QC, Canada; [sup.2]Department of Urology, Montpellier University Hospital, Montpellier, France; [sup.3]Department of Urology, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; [sup.4]Cancer Prognosis and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada; [sup.5]Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC, Canada; [sup.6]Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; [sup.7]Department of Urology, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. 4:17 p.m. P91. Indocyanine Green (ICG): A Novel Approach to Pelvic Lymph Node Identification in Radical Cystectomy Specimens.Jennifer Gordetsky, Hani Rashid, Guan Wu, Christopher Silvers, Edward M. Messing, Jorge Yao, Dragan GolijaninUniversity of Rochester, Rochester, NY, USA. 4:20 p.m. Discussion 4:30 p.m. Adjourn 4:30 - 5:30 p.m. Industry-sponsored Symposium 6:45 - 10 p.m. Fun Night - Pittsburgh Pirates Baseball Game

Saturday, September 25, 2010

7:30 - 8:30 a.m. Annual Business Meeting 7:30 - 8:30 a.m. Residents Breakfast: Public Speaking and DebateJim Dutcher, University of Pittsburgh, Pittsburgh, PA8:30 - 8:45 a.m. Best-of-Poster SessionPresented by moderators of previous day's poster sessions 8:45 - 9:30 a.m. Plenary VINOTES and LESSJeffrey Cadeddu, UT Southwestern Medical Center, Dallas, TX9:30 - 9:45 a.m. Residents DebateTopic: The Management of a Small Renal Tumor 9:45 - 10 a.m. Break 10 - 10:45 a.m. Plenary VII Trauma Richard Santucci, Detroit Medical Center, Detroit, MI10:45 - 11 a.m. Residents DebateTopic: The Management of Urethral Stricture Disease 11 - 11:45 a.m. Plenary Session VIIIEvidence-based Medicine as it Relates to OncologyBadrinath Konety, University of Minnesota, Minneapolis, MN11:45 - Noon Residents DebateTopic: The Management of Advanced Prostate Cancer Noon Adjourn
Gale Copyright: Copyright 2010 Gale, Cengage Learning. All rights reserved.